$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000168316823008275 Filed on November 17, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$282.3K	$318.4K	$60.65K
YoY Change	296.77%	424.9%	-90.44%
Cost Of Revenue	$427.0K	$201.4K	$42.44K
YoY Change	385.8%	374.53%	-91.86%
Gross Profit	-$144.7K	$117.0K	$18.21K
YoY Change	764.28%	542.27%	-83.98%
Gross Profit Margin	-51.24%	36.74%	30.03%
Selling, General & Admin	$1.014M	$441.5K	$674.1K
YoY Change	19.93%	-34.51%	103.98%
% of Gross Profit		377.42%	3701.35%
Research & Development	$461.5K	$305.9K	$133.1K
YoY Change	132.87%	129.79%	139.73%
% of Gross Profit		261.48%	730.85%
Depreciation & Amortization	$40.81K	$43.72K	$41.85K
YoY Change	-3.66%	4.48%	1.92%
% of Gross Profit		37.38%	229.78%
Operating Expenses	$1.475M	$1.147M	$992.2K
YoY Change	35.89%	15.63%	13.88%
Operating Profit	-$1.620M	-$1.030M	-$974.0K
YoY Change	46.95%	5.78%	28.57%
Interest Expense	-$29.94K	-$7.900K	-$28.85K
YoY Change	-3094.0%	-72.62%	-96.15%
% of Operating Profit
Other Income/Expense, Net	$94.04K	$62.27K	$31.95K
YoY Change	-184.14%	94.91%	-105.51%
Pretax Income	-$1.618M	-$968.0K	-$942.0K
YoY Change	53.38%	2.76%	-29.58%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.618M	-$968.0K	-$942.0K
YoY Change	53.38%	2.76%	-29.58%
Net Earnings / Revenue	-572.96%	-304.06%	-1553.1%
Basic Earnings Per Share		-$0.01	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	64.82M shares	64.82M shares	43.42M shares
Diluted Shares Outstanding		65.17M shares	43.46M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$465.0K	$1.448M	$6.147M
YoY Change	-89.55%	-76.45%	-35.53%
Cash & Equivalents	$428.3K	$1.409M	$6.062M
Short-Term Investments	$36.74K	$39.17K	$84.82K
Other Short-Term Assets	$96.30K	$109.9K	$183.6K
YoY Change	-32.35%	-40.13%	20.41%
Inventory	$282.1K	$300.0K	$49.11K
Prepaid Expenses	$96.30K	$109.9K	$183.6K
Receivables	$164.4K	$172.9K	$137.5K
Other Receivables	$20.52K	$10.00K	$13.06K
Total Short-Term Assets	$1.028M	$2.041M	$6.591M
YoY Change	-78.61%	-69.04%	-34.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.282M	$4.120M	$4.267M
YoY Change	1.26%	-3.44%	-2.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.14K	$23.42K	$34.30K
YoY Change	-27.42%	-31.72%	5096.97%
Total Long-Term Assets	$4.306M	$4.358M	$4.468M
YoY Change	-4.64%	-2.46%	0.9%
TOTAL ASSETS
Total Short-Term Assets	$1.028M	$2.041M	$6.591M
Total Long-Term Assets	$4.306M	$4.358M	$4.468M
Total Assets	$5.334M	$6.399M	$11.06M
YoY Change	-42.79%	-42.14%	-23.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$482.5K	$285.2K	$168.6K
YoY Change	80.25%	69.16%
Accrued Expenses	$90.17K	$84.04K	$103.3K
YoY Change	-20.25%	-18.68%	85.76%
Deferred Revenue
YoY Change
Short-Term Debt	$1.000M	$1.000M	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$1.658M	$1.409M	$2.278M
YoY Change	19.49%	-38.14%	261.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$130.9K	$12.34K	$12.34K
YoY Change	960.8%	0.0%
Total Long-Term Liabilities	$130.9K	$135.3K	$202.1K
YoY Change	-26.61%	-33.05%	127.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.658M	$1.409M	$2.278M
Total Long-Term Liabilities	$130.9K	$135.3K	$202.1K
Total Liabilities	$1.789M	$1.545M	$2.481M
YoY Change	14.24%	-37.72%	245.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.58M	-$20.96M	-$16.81M
YoY Change	26.41%	24.72%	37.6%
Common Stock	$64.77K	$64.77K	$43.53K
YoY Change	48.79%	48.8%	0.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$400.00
YoY Change
Treasury Stock Shares			400.0K shares
Shareholders Equity	$3.546M	$4.854M	$8.579M
YoY Change
Total Liabilities & Shareholders Equity	$5.334M	$6.399M	$11.06M
YoY Change	-42.79%	-42.14%	-23.41%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.618M	-$968.0K	-$942.0K
YoY Change	53.38%	2.76%	-29.58%
Depreciation, Depletion And Amortization	$40.81K	$43.72K	$41.85K
YoY Change	-3.66%	4.48%	1.92%
Cash From Operating Activities	-$925.2K	-$993.5K	-$685.7K
YoY Change	76.97%	44.9%	28.76%
INVESTING ACTIVITIES
Capital Expenditures	$330.00	$290.00	$510.00
YoY Change	-89.0%	-43.14%	-107.41%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$14.77K	$89.29K
YoY Change	-100.0%	-83.46%
Cash From Investing Activities	-$320.00	$14.47K	$89.80K
YoY Change	-99.05%	-83.89%	-1405.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-48.36K	1.034M	0.000
YoY Change	-95.83%		-100.0%
NET CHANGE
Cash From Operating Activities	-925.2K	-993.5K	-685.7K
Cash From Investing Activities	-320.0	14.47K	89.80K
Cash From Financing Activities	-48.36K	1.034M	0.000
Net Change In Cash	-973.9K	55.23K	-595.9K
YoY Change	-43.21%	-109.27%	-107.31%
FREE CASH FLOW
Cash From Operating Activities	-$925.2K	-$993.5K	-$685.7K
Capital Expenditures	$330.00	$290.00	$510.00
Free Cash Flow	-$925.5K	-$993.8K	-$686.2K
YoY Change	76.02%	44.84%	30.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount		usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
	FCUV	Common Stock Issued For Prior Period Service CommonStockIssuedForPriorPeriodService		usd
	FCUV	Common Stock Issued For Cashless Exercise Of Warrants CommonStockIssuedForCashlessExerciseOfWarrants		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40770
	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3355876
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2311 E. Locust Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91761
	dei	City Area Code CityAreaCode	(626)
	dei	Local Phone Number LocalPhoneNumber	272-3883
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	FCUV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64821817	shares
CY2023Q3	us-gaap	Cash Cash	1408687	usd
CY2022Q4	us-gaap	Cash Cash	4343426	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	172903	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78313	usd
CY2023Q3	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	0	usd
CY2022Q4	FCUV	Accounts Receivable Related Party Current AccountsReceivableRelatedPartyCurrent	34507	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	299973	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	109941	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	142342	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	39165	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	105470	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2040669	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4807830	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4119973	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	214900	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	23420	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33264	usd
CY2023Q3	us-gaap	Assets Assets	6398962	usd
CY2022Q4	us-gaap	Assets Assets	9323060	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	285206	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	267685	usd
CY2023Q3	FCUV	Related Party Loan RelatedPartyLoan	1000000	usd
CY2022Q4	FCUV	Related Party Loan RelatedPartyLoan	0	usd
CY2023Q3	FCUV	Treasurys Stock Payable TreasurysStockPayable	0	usd
CY2022Q4	FCUV	Treasurys Stock Payable TreasurysStockPayable	1000000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40255	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6496	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	84036	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1409497	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387239	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	122959	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	135294	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	178287	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1544791	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1565526	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64771817	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64771817	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65296383	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65296383	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	64771	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	65297	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1183040	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	400000	shares
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	385686	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2000000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26100446	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27514733	usd
CY2023Q3	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	46100	usd
CY2022Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	48075	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20964470	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6990	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6543	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4854171	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6398962	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9323060	usd
CY2023Q3	us-gaap	Revenues Revenues	318370	usd
CY2022Q3	us-gaap	Revenues Revenues	60654	usd
	us-gaap	Revenues Revenues	769856	usd
	us-gaap	Revenues Revenues	282463	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	201394	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	42441	usd
	us-gaap	Cost Of Revenue CostOfRevenue	531397	usd
	us-gaap	Cost Of Revenue CostOfRevenue	243004	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	116976	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	18213	usd
	us-gaap	Gross Profit GrossProfit	238459	usd
	us-gaap	Gross Profit GrossProfit	39459	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	33636	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	76984	usd
	us-gaap	Selling Expense SellingExpense	108570	usd
	us-gaap	Selling Expense SellingExpense	132871	usd
CY2023Q3	us-gaap	Officers Compensation OfficersCompensation	267002	usd
CY2022Q3	us-gaap	Officers Compensation OfficersCompensation	265449	usd
	us-gaap	Officers Compensation OfficersCompensation	827939	usd
	us-gaap	Officers Compensation OfficersCompensation	874739	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	305872	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	133109	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	925345	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	862214	usd
CY2023Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	132914	usd
CY2022Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150943	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	506878	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	686150	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	407851	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	365694	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1212486	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1586660	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	403761	shares
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1147275	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	992179	usd
	us-gaap	Operating Expenses OperatingExpenses	3581218	usd
	us-gaap	Operating Expenses OperatingExpenses	4142634	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1030299	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-973966	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3342759	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4103175	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3035	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2635	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27519	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2885	usd
CY2023Q3	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
CY2022Q3	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	0	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-17102	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	42101	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	10463	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-32525	usd
CY2023Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	12247	usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-31486	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-2002	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-21205	usd
CY2023Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	40731	usd
CY2022Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	39172	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	121024	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	117513	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29425	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20476	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23566	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	164260	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	62266	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31946	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	242317	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	230928	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-968033	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-942020	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3100442	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3872247	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-968033	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-942020	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3100442	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	239	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4596	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	447	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-121	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-968272	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-937424	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3100889	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3872126	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65171817	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65171817	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65193654	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65193654	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58678098	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58678098	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65035833	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65035833	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5639341	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	133402	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14700	usd
CY2023Q3	FCUV	Amendment Stock Purchase Agreement Treasury Stock AmendmentStockPurchaseAgreementTreasuryStock	35000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-239	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-968033	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4854171	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11341556	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	195751	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-21020	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4596	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-942020	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8578863	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	400208	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	183004	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	420686	usd
	FCUV	Amendment Stock Purchase Agreement Treasury Stock AmendmentStockPurchaseAgreementTreasuryStock	35000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-447	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3100442	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4854171	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	652501	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	663900	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4717	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8578863	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3100442	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6871	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	72108	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-21133	usd
	us-gaap	Depreciation Depreciation	127171	usd
	us-gaap	Depreciation Depreciation	123908	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28741	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	10463	usd
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-32525	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-2002	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-21205	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-0	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	158547	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	61747	usd
	FCUV	Gain On Bargain Purchase GainOnBargainPurchase	-0	usd
	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	183004	usd
	FCUV	Share Based Compensation Shares Value ShareBasedCompensationSharesValue	671901	usd
	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	400208	usd
	FCUV	Share Based Compensation Options Value ShareBasedCompensationOptionsValue	652500	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	101461	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32257	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-34507	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	45413	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	196201	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5087	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	10000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-31811	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-116648	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-8388	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1998	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	25585	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	226468	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	53709	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-120121	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	33759	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17406	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-58987	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-94542	usd
	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	0	usd
	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	12335	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2603545	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2435157	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20294	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39193	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	144907	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	768949	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	219673	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	630404	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54472	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-177738	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1385686	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-385686	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3352	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2934739	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2616247	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1408687	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6062418	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	13142	usd
	us-gaap	Interest Paid Net InterestPaidNet	8794	usd
	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	264641	usd
	FCUV	Right Of Use Asset Obtained In Exchange For Operating Lease Liability1 RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability1	0	usd
	FCUV	Treasury Stock Payable TreasuryStockPayable	0	usd
	FCUV	Treasury Stock Payable TreasuryStockPayable	2000000	usd
	FCUV	Cashless Exercise Of Options CashlessExerciseOfOptions	41401	usd
	FCUV	Cashless Exercise Of Options CashlessExerciseOfOptions	612662	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3100442	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20964470	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zLNxLuoVfU6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zeWdeJZYam3">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of-use asset with the estimate discount rate and lease liability, useful lives of property and equipment, useful lives of intangible assets, allowance for doubtful accounts, inventory reserves, stock option valuation, share-based compensation, fair value of warrants, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	616174	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3120763	usd
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	229843	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	222972	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zJq6YjsCHMx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_863_zkn4ZoNG6o5i">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2603545	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2435157	usd
	us-gaap	Depreciation Depreciation	127171	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2023Q2	us-gaap	Stock Dividends Shares StockDividendsShares	21592164	shares
CY2023Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	39165	usd
CY2022Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	105470	usd
	us-gaap	Depreciation Depreciation	123908	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	9862	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	75434	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	497092	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	305041	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zHH4QGioSdg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_864_zvgnpQ4jBP7k">Reclassification</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the unaudited condensed consolidated financial statements for the prior period to the current year’s presentation. Such reclassifications have no effect on net income as previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1051	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3767	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	298922	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100005	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	299973	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4920474	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4902400	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	800501	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673770	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4119973	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2023Q3	us-gaap	Depreciation Depreciation	43723	usd
CY2022Q3	us-gaap	Depreciation Depreciation	41845	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28741	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28741	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	101544	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	111114	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8219	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	230739	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	23744	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	206995	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	104156	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	280311	usd
CY2023Q3	FCUV	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	264650	usd
CY2022Q4	FCUV	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	353074	usd
CY2023Q3	FCUV	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	49750	usd
CY2022Q4	FCUV	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	99738	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	214900	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	84036	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	122959	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2022	FCUV	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P2Y2M1D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64771817	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64771817	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65296383	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65296383	shares
CY2023Q3	us-gaap	Litigation Reserve LitigationReserve	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	318370	usd
CY2023Q3	FCUV	Revenue Related Party RevenueRelatedParty	0	usd
CY2023Q3	us-gaap	Revenues Revenues	318370	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	201394	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	116976	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	33636	usd
CY2023Q3	us-gaap	Officers Compensation OfficersCompensation	267002	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	305872	usd
CY2023Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	132914	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	407851	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1147275	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1030299	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3035	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-17102	usd
CY2023Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	12247	usd
CY2023Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	40731	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29425	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	62266	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-968033	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-968033	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54686	usd
CY2022Q3	FCUV	Revenue Related Party RevenueRelatedParty	5968	usd
CY2022Q3	us-gaap	Revenues Revenues	60654	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	42441	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	18213	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	76984	usd
CY2022Q3	us-gaap	Officers Compensation OfficersCompensation	265449	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	133109	usd
CY2022Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150943	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	365694	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	992179	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-973966	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2635	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	42101	usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-31486	usd
CY2022Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	39172	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20476	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31946	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-942020	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-942020	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	769856	usd
	FCUV	Revenue Related Party RevenueRelatedParty	0	usd
	us-gaap	Revenues Revenues	769856	usd
	us-gaap	Cost Of Revenue CostOfRevenue	531397	usd
	us-gaap	Gross Profit GrossProfit	238459	usd
	us-gaap	Selling Expense SellingExpense	108570	usd
	us-gaap	Officers Compensation OfficersCompensation	827939	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	925345	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	506878	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1212486	usd
	us-gaap	Operating Expenses OperatingExpenses	3581218	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3342759	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27519	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	61747	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	10463	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-2002	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	121024	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23566	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	242317	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3100442	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3100442	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	242675	usd
	FCUV	Revenue Related Party RevenueRelatedParty	39788	usd
	us-gaap	Revenues Revenues	282463	usd
	us-gaap	Cost Of Revenue CostOfRevenue	243004	usd
	us-gaap	Gross Profit GrossProfit	39459	usd
	us-gaap	Selling Expense SellingExpense	132871	usd
	us-gaap	Officers Compensation OfficersCompensation	874739	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	862214	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	686150	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1586660	usd
	us-gaap	Operating Expenses OperatingExpenses	4142634	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4103175	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2885	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-32525	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-21205	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	117513	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	164260	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	230928	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3872247	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3872247	usd
CY2023Q3	us-gaap	Assets Assets	6398962	usd
CY2022Q4	us-gaap	Assets Assets	9323060	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	61747	usd

Files In Submission

Name	View Source	Status
0001683168-23-008275-index-headers.html	Edgar Link	pending
0001683168-23-008275-index.html	Edgar Link	pending
0001683168-23-008275.txt	Edgar Link	pending
0001683168-23-008275-xbrl.zip	Edgar Link	pending
fcuv-20230930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
focus_ex1001.htm	Edgar Link	pending
focus_ex3101.htm	Edgar Link	pending
focus_ex3102.htm	Edgar Link	pending
focus_ex3201.htm	Edgar Link	pending
fcuv-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fcuv-20230930_pre.xml	Edgar Link	unprocessable
fcuv-20230930_lab.xml	Edgar Link	unprocessable
focus_ex3202.htm	Edgar Link	pending
focus_i10q-093023.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fcuv-20230930_cal.xml	Edgar Link	unprocessable
focus_i10q-093023_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q4 Form 10-Q Financial Statement

#000168316823008275 Filed on November 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q4 Form 10-Q Financial Statement

#000168316823008275 Filed on November 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv